hematoxylin has been researched along with tacrolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Hazzaa, HH; Ibrahim, SS | 1 |
Adami, V; Astolfi, A; Barreca, ML; Biasini, E; Biggi, S; Bonetto, V; Dalle Vedove, A; Gatto, P; Lolli, G; Luotti, S; Massignan, T; Pancher, M; Stincardini, C | 1 |
2 other study(ies) available for hematoxylin and tacrolimus
Article | Year |
---|---|
Topical pimecrolimus effect on Fas inducing apoptosis in oral lichen planus: a clinical immunohistochemical study.
Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Apoptosis; Calcineurin Inhibitors; Coloring Agents; fas Receptor; Female; Follow-Up Studies; Gels; Gingival Diseases; Glucocorticoids; Hematoxylin; Humans; Immunosuppressive Agents; Keratinocytes; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; Ointments; Pain Measurement; Tacrolimus; Tongue Diseases; Treatment Outcome; Triamcinolone Acetonide | 2012 |
Identification of compounds inhibiting prion replication and toxicity by removing PrP
Topics: Animals; Casein Kinase II; Cell Line, Tumor; Cell Membrane; Cell Survival; Drug Evaluation, Preclinical; Fluorescent Dyes; Gene Expression; Green Fluorescent Proteins; Harmaline; HEK293 Cells; Hematoxylin; Humans; Mice; Neuroblastoma; Prions; PrPC Proteins; Quinacrine; Tacrolimus | 2020 |